Wiley Online Library : Journal of Oral Pathology & Medicine
13 followers 2 articles/week
Molecular pathogenesis of ameloblastoma

Abstract Ameloblastoma (AM) is a benign, although aggressive, epithelial odontogenic tumour originating from tooth-forming tissues or remnants. Its aetiopathogenesis remains unclear; however, molecular analysis techniques have allowed researchers to progress in understanding its genetic basis. The high frequency of BRAF p.V600E as a main driver mutation...

Fri Apr 26, 2024 11:02
Basal differentiation and expression status of SOX2 and KLF4 in basal layers are prognostic factors for disease‐specific survival in oral squamous cell carcinoma

Abstract Background Basal differentiation in oral squamous cell carcinoma is usually detected at invasive sites. However, its significance as a prognostic value has been poorly investigated. Methods COL17 was selected as a basal differentiation marker because of its stable expression in the basal-like cells of oral squamous cell carcinoma. Sixty-five...

Thu Apr 25, 2024 11:30
Deep neural network uncertainty estimation for early oral cancer diagnosis

Abstract Background Early diagnosis in oral cancer is essential to reduce both morbidity and mortality. This study explores the use of uncertainty estimation in deep learning for early oral cancer diagnosis. Methods We develop a Bayesian deep learning model termed ‘Probabilistic HRNet’, which utilizes the ensemble MC dropout method on HRNet. Additionally,...

Thu Apr 18, 2024 14:26
Issue Information

Journal of Oral Pathology &Medicine, Volume 53, Issue 4, Page i-iii, April 2024.

Wed Apr 17, 2024 14:47
Revolutionizing oral pathology and medicine: The artificial intelligence advantage

Journal of Oral Pathology &Medicine, Volume 53, Issue 4, Page 233-235, April 2024.

Fri Apr 12, 2024 11:47
Recent advances in patient‐derived tumor organoids for reconstructing TME of head and neck cancer

Abstract Background The differences between existing preclinical models and the tumor microenvironment in vivo are one of the significant challenges hindering cancer therapy development. Patient-derived tumor organoids (PDTO) can highly retain tumor heterogeneity. Thus, it provides a more reliable platform for research in tumor biology, new drug screening,...

Tue Apr 2, 2024 13:55

Build your own newsfeed

Ready to give it a go?
Start a 14-day trial, no credit card required.

Create account